It remains to be determined whether, and how much of, the therapeutic effect of SOS1 ablation is due to loss of activation of the resident KRASG12D mutant proteins or the non-mutated KRASWT proteins of the tumor/stromal cells. This evidence concerns the gene SOS1 and neoplasm.